Evidence map›Paper›PMID 42669597›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Deubiquitination of Vangl by USP6 and USP32 Regulates Planar Cell Polarity Signaling.

Fangzi Zha, Di Feng, Ziru Xue, Zhiying Liu, Xiaochen Lin, Zhe Wang, Ling Xu, Jasper Fuk Woo Chan, Martin Cheung, Michael Shing Yan Huen and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Fangzi Zha *School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Di Feng *School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0002-1444-3510
Ziru XueShanghai Key Laboratory of Cancer Systems Regulation and Clinical Translation, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhiying LiuSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Xiaochen LinSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Zhe WangSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ling XuSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Jasper Fuk Woo ChanDepartment of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0001-6336-6657
Martin CheungSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0002-3471-8534
Michael Shing Yan HuenSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Yusong GuoDivision of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, China.ORCID https://orcid.org/0000-0002-5539-599X
Kui Ming ChanDepartment of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0001-6430-3340
Yun LiuShanghai Key Laboratory of Cancer Systems Regulation and Clinical Translation, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Bo GaoSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0002-8684-5199

Funding

Hong Kong Research Grants Council 17101422Hong Kong Research Grants Council 17114321Hong Kong Research Grants Council GRF_17118120Lo Kwee Seong Foundation, and Innovation Technology Commission Fund (Health@InnoHK at Center for Translational Stem Cell Biology)National Natural Science Foundation 32170711
6 · The paper itself

Abstract

Planar cell polarity (PCP) signaling is an evolutionarily conserved mechanism regulating polarized cellular and tissue behaviors in diverse morphogenetic and physiological processes. Disruption or aberrant activation of PCP signaling can cause developmental defects or promote cancer malignancy. Vangl1 and Vangl2 are redundant core PCP components, and their protein levels are tightly controlled to maintain appropriate PCP signaling. Here, we identify two deubiquitinases, USP6 and USP32, that stabilize Vangl proteins through distinct ubiquitin linkage-specific mechanisms. USP6 primarily removes K33-linked and multi-monoubiquitin signals from plasma membrane-associated Vangl2, whereas USP32 removes K48-linked ubiquitin chains from Golgi/ER-localized Vangl2, thereby regulating distinct subcellular pools of Vangl2. Given that USP6 was previously reported to be a hominoid-specific gene originating from USP32, our findings suggest evolutionary refinement in PCP regulation. Consistent with these biochemical functions, genetic interaction studies demonstrate that Usp32 cooperates with Vangl genes to regulate PCP signaling during mouse embryogenesis. In pancreatic ductal adenocarcinoma, USP32 and VANGL1 are markedly upregulated and functionally promote cancer cell migration and metastasis. USP32 enhances metastatic behavior by stabilizing VANGL1 proteins. Together, our findings uncover a previously unrecognized regulatory mechanism of PCP signaling through USP6/USP32-mediated deubiquitination of Vangl proteins and highlight its roles in both developmental morphogenesis and cancer progression.

Indexed as

cell biologydeubiquitinating enzymedeubiquitinationpancreatic cancerplanar cell polarityubiquitin

Identifiers

PMID42669597
PMCPMC13526532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.